Page last updated: 2024-11-07

prednisolone acetate and Lacrimal Duct Obstruction

prednisolone acetate has been researched along with Lacrimal Duct Obstruction in 1 studies

prednisolone acetate: RN given refers to cpd with locant for acetate group in position 21 & (11 beta)-isomer

Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mimura, M1
Ueki, M1
Oku, H1
Sato, B1
Ikeda, T1

Other Studies

1 other study available for prednisolone acetate and Lacrimal Duct Obstruction

ArticleYear
Evaluation of granulation tissue formation in lacrimal duct post silicone intubation and its successful management by injection of prednisolone acetate ointment into the lacrimal duct.
    Japanese journal of ophthalmology, 2016, Volume: 60, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Dacryocystorhinostomy; Female; Follow-Up S

2016